Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,335,318
-$906,279 QoQ
Shares Held
678,377
+10.5% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#330
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRADLEY FOSTER & SARGENT INC/CT holds $254,262,538 across 12 Drug Manufacturers - General names. PFE ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
333,906 | $84,802,106 | |
| 2 | ABBV |
AbbVie Inc.
|
219,509 | $55,237,244 | |
| 3 | LLY |
ELI LILLY & Co
|
35,186 | $42,203,147 | |
| 4 | MRK |
Merck & Co., Inc.
|
287,164 | $36,900,574 | |
| 5 | PFE |
Pfizer Inc
This page
|
678,377 | $16,335,318 | |
| 6 | AMGN |
Amgen Inc
|
13,889 | $5,029,484 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
38,875 | $4,911,467 | |
| 8 | NVS |
Novartis AG
|
17,635 | $2,763,757 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,335,318 | 678,377 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,241,597 | 614,017 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,962,136 | 600,889 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $14,977,271 | 587,805 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $12,667,799 | 522,599 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $12,090,904 | 477,147 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $11,228,291 | 423,230 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $8,219,394 | 284,015 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $7,585,937 | 271,120 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $7,291,173 | 262,745 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,138,098 | 282,671 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,961,789 | 330,473 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $12,121,749 | 330,473 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $13,069,300 | 320,326 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $17,370,564 | 339,004 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $14,986,574 | 342,472 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,117,763 | 345,561 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $17,654,191 | 341,012 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,470,013 | 312,786 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $13,242,176 | 307,886 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $12,041,543 | 307,496 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $11,317,273 | 312,373 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $13,140,875 | 356,992 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $12,887,192 | 351,150 | Shares | Sole | 2020-10-26 | |
| 2020-03-31 | $11,598,999 | 355,362 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||